Expression of Recombinant Proteins in Yeast - - BioPharm International


Expression of Recombinant Proteins in Yeast

Other Yeast Systems

Table 3. Other yeast expression systems
A few other fungal systems have also been successfully used for recombinant protein production. Some of these systems are based on non-fermentation yeast species like Pichia methanolica and Hansenula polymorpha. These are similar to Pichia pastoris and can be grown to very high cell densities and high-level protein expression has been achieved. There is also a wide range of expression systems similar to the Pichia and Saccharomyces system available for recombinant protein expression. Table 3 shows some available expression technologies for these yeast systems.

This article is an excerpt from the chapter, "Advances in Improved Expression of Recombinant Proteins in Microbial Systems," in Eric S. Langer, Ed., Advances in Large-Scale Biopharmaceutical Manufacturing and Scale-Up Production (ASM Press, 2004).

Daniel Rudolph, Ph.D., is a process engineer in the process development group of Cambrex Bio Science Baltimore, Inc., 5901 E. Lombard Street, Baltimore, MD 21224, 410.563.9200,
. Co-authors Sriram Srinivasan, Ph.D., Don R. Durham, Ph.D., and Aaron Heifetz, Ph.D., previously served at Cambrex in the roles of process engineer, upstream process development group; vice president of technology; and vice president, general manager, and site director, respectively.


1. Rudolph D, Srinivasan S, Durham DR, Heifetz A. Advances in improved ex-pression of recombinant proteins in microbial systems. In: Langer ES, editor. Advances in large-scale biopharm-aceutical manufacturing and scale-up production. Volume 1: emerging tech-nologies and scientific advancements. Washington DC: ASM Press; 2004 October. p. 194-228.

2. Parekh RN, Shaw MR, Wittrup KD. An integrating vector for tunable, high copy, stable integration into the 1996dis-persed Ty delta sites of Saccharomyces cerevisiae. Biotechnol. Prog. 1996; 12(1):16-21.

3 Nasmyth KA, Reed SL. Isolation of genes by complementation in yeast: molecular cloning of a cell-cycle gene. Proc. Natl. Acad. Sci. USA 1980; 77(4):2119-2123.

4 Orr-Weaver TL, Szostak JW, Rothstein RJ. Yeast transformation: a model system for the study of recombination. Proc. Natl. Acad. Sci. USA 1981;78(10):6354-6358.

5 Carlson M, Botstein D. Two differentially regulated mRNAs with different 5' ends encode secreted with intracellular forms of yeast invertase. Cell 1982; 28(1): 145-154.

6 Rose MD, Novick P, Thomas JH, Botstein D, Fink GR. A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector. Gene 1987; 60(2-3):237-243.

7 Sikorski RS, Hieter P. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 1989; 122(1): 19-27.

8 Law RHP, Rowley MJ, Mackay IR, Corner B. Expression in Saccharomyces cerevisiae of antigenically and enzy-matically active recombinant glutamuic acid decarboxylase. J. of Biotechnology 1998; 61:57-68.

9 Bitter GA, Egan KM. Expression of heterologous genes in Saccharomyces cerevisiae from vectors utilizing the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Gene. 1984; 32(3):263-74.

blog comments powered by Disqus



FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here